| Ryan Richard Sullivan, MD | |
|
1229 Reserve Blvd, Suite 200, Spring Hill, TN 37174 | |
| (615) 302-5000 | |
| (615) 302-5006 |
| Full Name | Ryan Richard Sullivan |
|---|---|
| Gender | Male |
| Speciality | Allergy & Immunology - Allergy |
| Location | 1229 Reserve Blvd, Spring Hill, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417085606 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | 38819 (Tennessee) | Primary |
| Entity Name | Uvalde County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740288505 PECOS PAC ID: 7315832722 Enrollment ID: O20040216000884 |
News Archive
A surgical technique that requires the removal, restructure and re-implantation of the nasal septum (the partition of the nose between the nostrils) appears to be a useful option for repairing the hard-to-treat severely deviated septum, according to an article in the July/August issue of Archives of Facial Plastic Surgery.
By 1990, many doctors were recommending hormone replacement therapy to healthy middle-aged women and P.S.A. screening for prostate cancer to older men. Both interventions had become standard medical practice. But in 2002, a randomized trial showed that preventive hormone replacement caused more problems (more heart disease and breast cancer) than it solved. ... Then, in 2009, trials showed that P.S.A. screening led to many unnecessary surgeries and had a dubious effect on prostate cancer deaths.
A study of preschool-age children has shown key differences in the neural networks mediating language processing between those who stutter and those who do not.
Regado Biosciences, Inc., today announced the exercise of the over-allotment option granted to the underwriters to purchase 921,500 additional shares of common stock, at a public offering price of $4.00 per share, in connection with its previously announced initial public offering of 10,750,000 shares of common stock, bringing the total gross proceeds from the offering to $46,686,000, before deducting the underwriting discounts and commissions and other offering expenses payable by Regado Biosciences.
› Verified 2 days ago
| Entity Name | Uvalde County Hospital Authority |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1740288505 PECOS PAC ID: 7315832722 Enrollment ID: O20160613001680 |
News Archive
A surgical technique that requires the removal, restructure and re-implantation of the nasal septum (the partition of the nose between the nostrils) appears to be a useful option for repairing the hard-to-treat severely deviated septum, according to an article in the July/August issue of Archives of Facial Plastic Surgery.
By 1990, many doctors were recommending hormone replacement therapy to healthy middle-aged women and P.S.A. screening for prostate cancer to older men. Both interventions had become standard medical practice. But in 2002, a randomized trial showed that preventive hormone replacement caused more problems (more heart disease and breast cancer) than it solved. ... Then, in 2009, trials showed that P.S.A. screening led to many unnecessary surgeries and had a dubious effect on prostate cancer deaths.
A study of preschool-age children has shown key differences in the neural networks mediating language processing between those who stutter and those who do not.
Regado Biosciences, Inc., today announced the exercise of the over-allotment option granted to the underwriters to purchase 921,500 additional shares of common stock, at a public offering price of $4.00 per share, in connection with its previously announced initial public offering of 10,750,000 shares of common stock, bringing the total gross proceeds from the offering to $46,686,000, before deducting the underwriting discounts and commissions and other offering expenses payable by Regado Biosciences.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Richard Sullivan, MD 100 Blythewood Dr Ste A, Columbia, TN 38401-4828 Ph: (615) 302-5000 | Ryan Richard Sullivan, MD 1229 Reserve Blvd, Suite 200, Spring Hill, TN 37174 Ph: (615) 302-5000 |
News Archive
A surgical technique that requires the removal, restructure and re-implantation of the nasal septum (the partition of the nose between the nostrils) appears to be a useful option for repairing the hard-to-treat severely deviated septum, according to an article in the July/August issue of Archives of Facial Plastic Surgery.
By 1990, many doctors were recommending hormone replacement therapy to healthy middle-aged women and P.S.A. screening for prostate cancer to older men. Both interventions had become standard medical practice. But in 2002, a randomized trial showed that preventive hormone replacement caused more problems (more heart disease and breast cancer) than it solved. ... Then, in 2009, trials showed that P.S.A. screening led to many unnecessary surgeries and had a dubious effect on prostate cancer deaths.
A study of preschool-age children has shown key differences in the neural networks mediating language processing between those who stutter and those who do not.
Regado Biosciences, Inc., today announced the exercise of the over-allotment option granted to the underwriters to purchase 921,500 additional shares of common stock, at a public offering price of $4.00 per share, in connection with its previously announced initial public offering of 10,750,000 shares of common stock, bringing the total gross proceeds from the offering to $46,686,000, before deducting the underwriting discounts and commissions and other offering expenses payable by Regado Biosciences.
› Verified 2 days ago